MicroRNAs and fibrosis
Current Opinion in Nephrology and Hypertension, 06/01/2012
Clinical Article
Patel V et al. – Aberrant MicroRNA expression perturbs signaling pathways that lead to progression of kidney fibrosis. Thus, MicroRNAs represent novel biomarkers and therapeutic targets in the treatment of kidney fibrosis.



